DaVita (DVA) Stock
NASDAQ · DVA
183.86
Fundamentals
Market cap
$11.73B
Price / Earnings ratio
13.8x
Price / Sales ratio
0.8x
Price / Book ratio
-15.3x
Return on assets
0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About DaVita
DaVita is a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe. The company is the largest provider of kidney care services in the U.S. and has been a leader in clinical quality and innovation for 20 years
SectorHealthcare
IndustryMedical Care Facilities
Employees78,000
CEOMr. Javier J. Rodriguez
IPO DateOct 31, 1995
HeadquartersDenver, CO
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Javier J. Rodriguez | CEO & Executive Director | 1971 |
| Mr. Joel Ackerman | CFO & Treasurer | 1965 |
| Ms. Kathleen Alyce Waters | Chief Legal & Public Affairs Officer | 1968 |
| Mr. James O. Hearty | Chief Compliance Officer | 1969 |
| Mr. David P. Maughan | Chief Operating Officer of DaVita Kidney Care | 1977 |
| Mr. Christopher Michael Berry CPA | Group VP & Chief Accounting Officer | 1975 |
| Nic Eliason | Group Vice President of Investor Relations | — |
| Ms. Stephanie Hendrickson | Chief People Officer | — |
| Mr. Misha Palecek | Chief Transformation Officer of U.S. Kidney Care Business | — |
| Dr. Jeffrey Allen Giullian | Chief Medical Officer of Kidney Care | — |
Fundamentals
Valuation
Market cap$11.73B
Price-to-sales ratio0.83
Price-to-book value-15.27
Price-earnings ratio13.80
Return on Equity-133.00%
Return on Sales0.12%
Return on Assets0.05%
PEG ratio0.47
Earnings Per Share
Earnings Per Share$12.41
Income Statement
Average volume642,693
EBITDA$2.39B
1 year high (52w)$247.49
1 year low (52w)$101.00
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



